Table 6.
Group | n | VEGF | Aβ1-42 | α7-nAChRs | RAGE | LRP-1 |
---|---|---|---|---|---|---|
C57 sham-operated | 10 | 1.000±0.172 | 1.000±0.073 | 1.000±0.131 | 1.000±0.074 | 1.000±0.203 |
C57 ischemia | 10 | 1.710±0.088a | 0.930±0.122 | 1.410±0.153a | 1.052±0.091 | 0.970±0.072 |
APP/PS1 model | 10 | 0.620±0.045a | 1.550±0.124d | 1.560±0.065a | 1.150±0.116 | 0.800±0.103 |
APP/PS1 ischemia | 10 | 0.500±0.046a | 2.730±0.270a | 2.250±0.083a | 1.518±0.077a | 0.600±0.054d |
C57BL ischaemic + aspirin | 10 | 1.330±0.022b | 1.040±0.111 | 1.380±0.142 | 1.050±0.062 | 1.160±0.104 f |
C57BL ischaemic + SLT | 10 | 1.880±0.042 | 0.960±0.115 | 1.110±0.144 | 1.010±0.052 | 1.050±0.200 |
APP/PS1 + SLT | 10 | 1.040±0.081c | 1.200±0.132c | 1.160±0.120c | 1.020±0.079c | 1.260±0.064c |
APP/PS1 ischaemic + donepezil hydrochloride group | 10 | 0.580±0.084 | 1.560±0.127c | 1.250±0.256c | 1.230±0.075e | 1.180±0.085c |
APP/PS1 ischaemic + SLT | 10 | 0.839±0.095c | 1.460±0.273c | 1.480±0.135ac | 1.240±0.151ac | 1.220±0.032c |
Notes: ischaemic treatment: both right and left common carotid arteries were separated, and the arterial blood vessel was stimulated with a temperature-controlled current of 80 mu A using an in vivo thrombometer to cause thrombosis. The APP/PS1 ischaemic + donepezil hydrochloride group were administered intragastrically with 20 mg·kg-1·d-1 of donepezil hydrochloride. The C57BL ischaemic + aspirin group were administered intragastrically with 32 mg·kg-1·d-1 of aspirin, the SLT group were administered intragastrically with 32 mg·kg-1·d-1 of SLT and the control group were given 32 mg·kg-1·d-1 of solvent. Duration: two months. SLT: Sailuotong; APP: amyloid precursor protein; PS1: presenilin-1; VEGF: vascular endothelial growth factor; Aβ1-42: amyloid-beta1-42; α7-nAChRs: α7-nicotinic acetylcholine receptor; RAGE: anti-receptor for advanced glycation endproducts; LRP-1: lipoprotein receptor-related-protein-1. One-way analysis of variance was employed to make comparisons among groups, and in the case of the normal distribution, Tukey’s post hoc test was conducted; otherwise, the Kruskal-Wallis test was adopted. Compared with C57 sham-operated group, aP <0.01, dP < 0.05; compared with C57 ischemia group, bP < 0.01, fP < 0.05; compared with APP/PS1 ischemia group, cP < 0.01, eP < 0.05.